Purple Biotech (PPBT) Invested Capital (2015 - 2017)

Purple Biotech (PPBT) has 3 years of Invested Capital data on file, last reported at $3.0 million in Q4 2017.

• On a quarterly basis, Invested Capital rose 455.11% year-over-year to $3.0 million in Q4 2017; TTM through Jun 2019 was $3.0 million, a 15.26% decrease from a year earlier, with the FY2017 full-year figure at $3.0 million, up 455.11% from the prior year.
• Invested Capital for Q4 2017 stood at $3.0 million, up from $548000.0 in the prior quarter.
• Over the last five years, Invested Capital for PPBT reached as high as $3.0 million in Q4 2017 and fell as low as $548000.0 in Q4 2016.
• Historically, Invested Capital has averaged $1.4 million across 3 years, with a median of $549000.0 in 2015.
• Across the five-year window, Invested Capital dropped 0.18% in 2016 and jumped 455.11% in 2017, its largest moves.
• Year by year, Invested Capital stood at $549000.0 in 2015, then retreated by 0.18% to $548000.0 in 2016, then soared by 455.11% to $3.0 million in 2017.
• Per Business Quant data, the three most recent Invested Capital figures were $3.0 million in Q4 2017, $548000.0 in Q4 2016, and $549000.0 in Q4 2015.